Rang	Name	Position
1	Mr. Arthur Kuan	President, Chairman & CEO
2	Mr. James M. DeTore	Chief Financial Officer
3	Mr. Joshua F. Patterson	General Counsel, Chief Compliance Officer & Secretary
4	Dr. Vijay Kasturi M.D.	Chief Medical Officer
5	Mr. Swapnil Bhargava Ph.D.	Chief Technical Officer
6	Ms. Amy Steele	Vice President of Finance & Administration
7	Ms. Sarah Connors	Vice President of Communications & Patient Advocacy
8	Mr. Bing Kung	Vice President of Corporate Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	RTW INVESTMENTS, LLC	7,88%	0,51 Mrd. USD
2	T. Rowe Price Investment Management,Inc.	7,58%	0,49 Mrd. USD
3	Decheng Capital LLC	7,19%	0,46 Mrd. USD
4	Wellington Management Company LLP	6,01%	0,39 Mrd. USD
5	BlackRock Inc	5,71%	0,37 Mrd. USD
6	FMR Inc	4,25%	0,27 Mrd. USD
7	TCG Crossover Management, LLC	4,14%	0,27 Mrd. USD
8	T. Rowe Price Associates, Inc.	4,12%	0,26 Mrd. USD
9	Vanguard Portfolio Management, LLC	3,49%	0,22 Mrd. USD
10	Vanguard Capital Management, LLC	3,42%	0,22 Mrd. USD
11	State Street Corp	2,99%	0,19 Mrd. USD
12	Foresite Capital Management VI LLC	2,67%	0,17 Mrd. USD
13	Geode Capital Management, LLC	1,80%	0,12 Mrd. USD
14	Seven Fleet Capital Management LP	1,71%	0,11 Mrd. USD
15	Franklin Templeton Inc	1,70%	0,11 Mrd. USD
16	EcoR1 Capital, LLC	1,69%	0,11 Mrd. USD
17	Bank of America Corp	1,64%	0,11 Mrd. USD
18	DV Trading LLC	1,62%	0,10 Mrd. USD
19	Avidity Partners Management LP	1,58%	0,10 Mrd. USD
20	UBS Group AG	1,48%	0,10 Mrd. USD